[1] |
Hunter W. The history of an aneurysm of the aorta with some remarkson aneurysms in general[J]. Med Obs Soc Phys Lond, 1757, 1: 323.
|
[2] |
Klein-Weigel PF, Elitok S, Ruttloff A, et al. Superior vena cava syndrome[J]. Vasa 2020, 49(6): 437-448.
|
[3] |
Bilyeu JA. Superior vena cava syndrome[J]. J Insur Med, 2001, 33: 349.
|
[4] |
Herscovici R, Szyper-Kravitz M, Altman A, et al. Superior vena cava syndrome: changing etiology in the third millennium[J]. Lupus, 2012, 21: 93-96.
|
[5] |
Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease[J]. Cardiovasc Intervent Radiol, 2006, 29: 319-322.
|
[6] |
Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review[J]. Clin Oncol (R Coll Radiol), 2002, 14(5): 338-351.
|
[7] |
Straka C, Ying J, Kong FM, et al. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome[J]. Springerplus, 2016, 5:229.
|
[8] |
Friedman T, Quencer KB, Kishore SA, et al. Malignant venous obstruction: superior vena cava syndrome and beyond[J]. Semin Intervent Radiol, 2017, 34: 398-408.
|
[9] |
Lazzarino M, Orlandi E, Paulli M, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features[J]. J Clin Oncol, 1993, 11(12): 2306-2313.
|
[10] |
Ni R, Amr M, Kalla A. Hodgkin lymphoma-associated superior vena cava syndrome: a case of report and review of the literature[J]. Am J Case Rep, 2021, 22:e929437.
|
[11] |
Arora Y, Carrillo RG. Lead-related superior vena cava syndrome: management and outcomes[J]. Heart Rhythm, 2021, 18(2):207-214.
|
[12] |
Stanford W, Doty DB. The role of venography and surgery in the treatment of patients with superior vena cava obstruction[J]. Ann Thorac Surg, 1986, 41(2): 158-163.
|
[13] |
Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology[J]. Medicine (Baltimore), 2006, 85(1): 37-42.
|
[14] |
Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome--a proposed classification system and algorithm for management[J]. J Thorac Oncol, 2008, 3(8): 811-814.
|
[15] |
Sheth S, Ebert MD, Fishman EK. Superior vena cava obstruction evaluation with MDCT[J]. Am J Roentgenol, 2010, 194(9): W345-W346.
|
[16] |
Kim HC, Chung SH, Park SH, et al. Systemic to pulmonary vena shunt in superior vena cava obstruction: depiction on computed tomography venography[J]. Acta Radiol, 2004, 45(3): 269-274.
|
[17] |
Yoel S, Erica S. Prevalence and etiology of focal liver opacification in patients with superior vena cava obstruction[J].J Comput Assist Tomogr, 2013, 37: 805-808.
|
[18] |
Loeffler JS, Leopold KA, Recht A, et al. Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome[J]. J Clin Oncol, 1986, 4(5): 716-721.
|
[19] |
Koegelenberg CF, Bolliger CT, Plekker DP, et al. Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome[J]. Eur Respir J, 2009, 33: 1389-1395.
|
[20] |
Pop D, Venissac N, Nadeemy AS, et al. Video-assisted mediastinoscopy in superior vena cava obstruction: to fear or not to fear?[J]. J Thorac Oncol, 2012, 7(2): 386-389.
|
[21] |
Zimmerman S, Davis M. Rapid fire: superior vena cava syndrome[J]. Emerg Med Clin North Am, 2018, 36: 577-584.
|
[22] |
Gloviczki P, Pairolero P, McKusick M, et al. Surgical treatment of superior vena cava syndrome//Gloviczki P, Yao J, eds. Handbook of venous disorders (2nd ed)[M]. London: Arnold; 2001: 408-417.
|
[23] |
熊刚, 杨康, 廖克龙, 等. 血管切除重建治疗癌性上腔静脉综合征[J]. 第三军医大学学报, 2005, 27(24): 2450-2452.
|
[24] |
Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome[J]. J Clin Oncol, 1984, 2:961-969.
|
[25] |
Nicholson AA, Ettles DF, Arnold A, et al. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy[J]. J Vasc Interv Radiol, 1997, 8(5): 781-788.
|
[26] |
Sato Y, Inaba Y, Yamaura H, et al. Malignant inferior vena cava syndrome and congestive hepatic failure treated by venous stent placement[J]. J Vasc Interv Radiol, 2012, 23(10): 1377-1380.
|
[27] |
Van Putten JW, Schlosser NJ, Vujaskovic Z, et al. Superior vena cava obstruction caused by radiation induced venous fibrosis[J]. Thorax, 2000, 55(3): 245-246.
|
[28] |
Pereira JR, Martins CJ, Ikari FK, et al. Neoadjuvant chemotherapy vs. radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): preliminary results ofa randomized phase II trial[J]. Eur J Cancer, 1999, 35(Suppl 4): 260.
|
[29] |
Scalese MJ, Hayes SL, Lott S. Antithrombotic therapy post endovascular stenting for superior vena cava syndrome[J]. Hosp Pharm, 2017, 52(10): 666.
|
[30] |
Haddad MM, Thompson SM, McPhail IR, et al. Is long-term anticoagulation required after stent placement for benign superior vena cava syndrome?[J]. J Vasc Interv Radiol, 2018, 29(12):1741-1747.
|
[31] |
Kalra M, Sen I, Gloviczki P. Endovenous and operative treatment of superior vena cava syndrome[J]. Surg Clin North Am, 2018, 98(2): 321-335.
|
[32] |
Wei S, Liu J, Li X, et al. A retrospective stenting study on superior vena cava syndrome caused by lung cancer[J]. Thorac Cancer, 2020, 11(7): 1835-1839.
|
[33] |
Straka C, Ying J, Kong FM, et al. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome[J]. Springerplus, 2016, 5: 229.
|
[34] |
Matthaiou N, Galanakis N, Kehagias E, et al. Endovascular treatment of malignant superior vena cava syndrome through upper-limb access: a comparison between venous-dedicated and conventional stents[J].J Vasc Interv Radiol, 2020, 31(12): 2066-2072.
|
[35] |
Fagedet D, Thony F, Timsit JF, et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy[J]. Cardiovasc Intervent Radiol, 2013, 36: 140-149.
|
[36] |
Da Ines D, Chabrot P, Motreff P, et al. Cardiac tamponade after malignant superior vena cava stenting: two case reports and brief review of the literature[J]. Acta Radiol, 2010, 51: 256-259.
|
[37] |
Siani A, Marcucci G, Accrocca F, et al. Endovascular central venous stenosis treatment ended with superior vena cava perforation, pericardial tamponade, and exitus[J]. Ann Vasc Surg, 2012, 26: 733.e9-12.
|
[38] |
Martin M, Baumgartner I, Kolb M, et al. Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndrome[J]. J Endovasc Ther, 2002, 9: 680-684.
|
[39] |
Sun K, Batra R, Markin NW, et al. Transesophageal echocardiogram-guided stent placement in superior vena cava syndrome secondary to granulomatous lung disease: a case series and literature review[J]. Vasc Endovascular Surg, 2017, 51(8): 562-566.
|